Halozyme Therapeutics reported $66.77M in Net Income for its fourth fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Net Income Change
Agios Pharmaceuticals AGIO:US $ -94.63M 5.86M
Aptinyx Inc APTX:US $ -19827000 217K
Cytokinetics CYTK:US $ -89.44M 58.88M
Immunogen IMGN:US $ -24.14M 13.03M
Intrexon XON:US $ -29.76M 9.71M
IONIS PHARMACEUT IONS:US $ 225M 307.47M
Minerva Neurosciences NERV:US $ -9.76M 11.54M
Nektar Therapeutics NKTR:US $ -145.65M 15.94M
Peregrine Pharmaceuticals PPHM:US $ 3.52M 2.78M